New Delhi, May 2 (IANS) Artificial intelligence (AI) could soon play a pivotal role in diagnosing and treating genetic disorders, according to a study.
The study, led by researchers at the Australian National University (ANU) in Australia marks a significant step toward more precise, personalised medicine by harnessing the power of new data tools, Xinhua news agency reported.
Published in Nature Communications, the study combines AI-powered protein models with genome sequencing to better understand how mutations affect human health.
It uncovered why some proteins are more vulnerable to harmful mutations than others, through the use of Google DeepMind AlphaFold’s cutting-edge AI to analyse the effects of every possible mutation across the full range of human proteins.
“Our study reveals that evolution has built resilience into the most essential proteins, shielding them from harmful mutations that disrupt protein stability. Less critical proteins seem not to have evolved this inherent ability to absorb damage,” said research lead Dan Andrews, Associate Professor at ANU.
Researchers from ANU’s John Curtin School of Medical Research and School of Computing help explain why seemingly less vital genes often play a larger role in genetic conditions.
Andrews said that genetic mutations are like the rain that all genes must endure — they are constant and unavoidable.
While some genes are very essential and are rarely observed, others “are a little less critical but are still important enough that human diseases occur when they contain mutations.”
The research helps prioritise treatments by identifying specific genetic pathways affected by mutations.
“It’s important to identify which genetic system is dysfunctional in a given person, which helps us potentially choose the most effective treatment,” Andrews said.
He noted that the study also applies to complex diseases with multiple mutations as it involves scoring genetic variation for its functional effects — crucial for identifying potentially broken genes.
Further, the study also shows a potential for clinical translation and the development of AI tools to help improve patient outcomes.
“Our future goals include developing automated systems to flag effective treatment for individuals, based on their genetic and pathology data,” Andrews said.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
